Healthcare Industry News: UCB
News Release - June 23, 2010
Stryker Announces Election of New DirectorKALAMAZOO, Mich., June 23 -- (Healthcare Sales & Marketing Network) -- Stryker Corporation (NYSE:SYK ) announced an increase in the size of its Board of Directors to nine and the election of Dr. Roch Doliveux as a director.
Dr. Doliveux has served since 2005 as Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company.
Dr. Doliveux has previously been a Chief Executive Officer of Pierre Fabre Pharmaceuticals and President, Schering-Plough International, a subsidiary of Schering-Plough Corporation.
Dr. Doliveux holds a master's degree in business from INSEAD, Fontainebleau, France. He also holds a Ph.D. in Veterinary Medicine from Ecole Nationale Veterinaire d'Alfort, Maisons-Alfort, France.
Stephen P. MacMillan, Chairman, President and Chief Executive Officer of Stryker Corporation, said, "Roch brings an outstanding combination of talents and experiences as a globally-minded healthcare executive with a strong focus on patients and innovation."
Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company provides innovative orthopaedic implants as well as state-of-the-art medical and surgical equipment to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsBreg Appoints Former Stryker President to Executive Chairman
Stryker Launches First 64-Wire Cobalt Chromium Flow Diverter in the US to Treat Brain Aneurysms
Stryker's Neuroform Atlas(R) Stent System granted an expanded indication, providing a new option for patients with aneurysms in the back of the brain